AXT Inc. Reports Q2 2025 Revenue Below Guidance at $17.5-$18 Million Due to Export Delays and Weak China Demand

Reuters
07-10
<a href="https://laohu8.com/S/AXTI">AXT Inc</a>. Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue Below Guidance at $17.5-$18 Million Due to Export Delays and Weak China Demand

AXT, Inc. (NasdaqGS: AXTI) has released a preliminary revenue range for the second quarter of 2025, ending June 30, 2025. The company expects revenue to be between $17.5 million and $18 million, which is below its previous guidance of $20 million to $22 million. This adjustment is attributed primarily to slower issuance of export control permits for gallium arsenide products and weaker demand in China. CEO Morris Young highlighted challenges stemming from the geopolitical environment but noted an increase in AI-related demand for indium phosphide in China. Additionally, AXT's subsidiary, Beijing Tongmei Xtal Technology Co., received its first export control permits for indium phosphide towards the end of the quarter. Despite the revenue shortfall, AXT anticipates delivering gross margins in the high single digits for Q2 2025. The full financial results for the second quarter are scheduled to be announced on July 31, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AXT Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250709272681) on July 09, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10